Net Loss: Chimerix Inc (NASDAQ:CMRX) reported a Q4 net loss of $18.2 million, a decrease from Q4 2022's net loss of $21.0 million. Research and Development: R&D expenses decreased to $15.6 million in ...
Source LinkNet Loss: Chimerix Inc (NASDAQ:CMRX) reported a Q4 net loss of $18.2 million, a decrease from Q4 2022's net loss of $21.0 million. Research and Development: R&D expenses decreased to $15.6 million in ...
Source Link
Comments